News Search

An expanding artificial heart valve being developed by Columbia surgeons and engineers could simplify treatment for many kids born with congenital heart disease.

Many Black Americans thought to have a high risk of developing kidney disease possess a genetic variant that eradicates the extra risk, a new study from Columbia researchers has found.

Columbia physicians and patients were essential in demonstrating the effectiveness of the world’s first CRISPR gene-editing therapy, now approved for use in the United States.